What are you looking for?

The CyberKnife allows patients to lie comfortably on the procedure table without anesthesia while the robotic arm moves, without touching them, to treat all areas of the tumor. Recovery is often immediate, given its low risk of complications and damage to healthy tissue. The CyberKnife treats brain cancer (benign and malignant); head and neck cancer; liver cancer; lung cancer; pancreatic cancer; prostate
cancer and other benign tumors. The procurement for this equipment is ongoing and it will be operational by January 2022. It will be
the first in Africa.